Navigation Links
Summary Notice of Proposed Settlement, Settlement Fairness Hearing, and Motion for Award of Attorneys' Fees and Reimbursement of Litigation Expenses
Date:11/16/2010

PHILADELPHIA, Nov. 16, 2010 /PRNewswire/ -- Berger & Montague, P.C. and Brower Piven, A Professional Corporation, Co-Lead Counsel for Lead Plaintiff and the Class in the Hemispherx Biopharma, Inc. securities class-action suit, announced the following:IN THE UNITED STATES DISTRICT COURTFOR THE EASTERN DISTRICT OF PENNSYLVANIA:IN RE HEMISPHERX:BIOPHARMA, INC. LITIGATION:CIVIL ACTION NO.  09-CV-5262-PSD:SUMMARY NOTICE OF PROPOSED SETTLEMENT, SETTLEMENT FAIRNESS HEARING, AND MOTION FOR AWARD OF ATTORNEYS' FEES AND REIMBURSEMENT OF LITIGATION EXPENSESTO:ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED THE COMMON STOCK OF HEMISPHERX BIOPHARMA, INC. ("HEMISPHERX") FROM FEBRUARY 18, 2009 THROUGH AND INCLUDING DECEMBER 1, 2009 (THE "CLASS PERIOD")PLEASE READ THIS NOTICE CAREFULLYIF YOU ARE A MEMBER OF THE CLASS DESCRIBED IN THIS NOTICE, YOUR RIGHTS WILL BE AFFECTED BY A CLASS ACTION LAWSUIT AND YOU MAY BE ENTITLED TO RECEIVE PAYMENTS PURSUANT TO A PROPOSED SETTLEMENTPursuant to Rule 23 of the Federal Rules of Civil Procedure and by Order of the United States District Court for the Eastern District of Pennsylvania dated October 20, 2010, a hearing will be held on January 20, 2011 at 10:00 a.m. in Courtroom 6B, United States Courthouse, 601 Market Street, Philadelphia, PA 19106, to determine (1) whether the proposed Settlement (the "Settlement") of the above-captioned action ("Action") for $3,600,000 should be approved by the Court as fair, reasonable, and adequate; (2) whether the motion of Co-Lead Counsel for an award of attorneys' fees and reimbursement of expenses should be approved; and (3) whether the Action should be dismissed with prejudice.

If you have not yet received in the mail the long-form version of the Notice of Pendency of Class Action and Proposed Settlement, Settlement Fairness Hearing, and Motion for Award of Attorneys' Fees and Reimbursement of Litigation Expenses (the "Notice") and Proof of Claim and Release Form ("Proof of C
'/>"/>

SOURCE Berger & Montague, P.C.; Brower Piven
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BYDUREON(TM) Safety and Tolerability Pooled Summary Data Presented at ADA 2010
2. Genmab A/S - Company Announcement Ofatumumab in Subcutaneous Study in Rheumatoid Arthritis Summary: Subcutaneous Administration of Ofatumumab Investigated in Phase I/II Study
3. Isis Reports New Data for Mipomersen in Routine High Cholesterol Patients and Provides Cumulative Safety Summary
4. Terumo Heart Reports Summary of DuraHeart(TM) LVAS Clinical Trial Results
5. EntreMed Receives Notice of NASDAQ Compliance
6. Caliper Life Sciences Third Quarter 2010 Financial Results Conference Call Notice
7. Incisive Surgical Issued Notice of Allowance for Key Absorbable Skin Stapler Patent
8. China Shenghuo Receives Notice from NYSE Amex LLC Regarding Listing Standards
9. KemPharm, Inc. Receives Notice of Issuance from USPTO on Second Patent Protecting Companys ADHD Prodrug Technology
10. KemPharm, Inc. Receives Notice of Issuance From USPTO on Patent Protecting Companys ADHD Prodrug Technology
11. Abviva Announces Notice of Canadian Patent for Technology Used in Breast Cancer Diagnostics and Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , June 25, 2015 ... of the "Veterinary / Animal Vaccines Market by ... report to their offering. The global ... by 2020 from $5,507.3 Million in 2015, at a ... Major factors fueling market growth are growing prevalence of ...
(Date:7/2/2015)... ATLANTA , July 2, 2015 Legal-Bay ... U.S. District Judge Joseph Goodwin in the ... (VA) consolidated 26 transvaginal mesh cases against Ethicon for ... nd . The cases for the 26 women include ... by a device made my Johnson & Johnson,s Ethicon ...
(Date:7/2/2015)... Agreement reinforces ...   ViiV Healthcare and Desano Pharmaceuticals (Desano) ... China of dolutegravir. The agreement will ... (API), and will allow ViiV Healthcare to offer a competitive ... name Tivicay®) for China and a ...
Breaking Medicine Technology:Veterinary / Animal Vaccines Market 2015 - Global Forecast to 2020 for the $7.19 Billion Industry 2Judge Sets Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 2Judge Sets Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 3ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 2ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 3ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 4ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 5ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 6
... and AMSTERDAM , July 15, 2010 ... company,CEO Dr. Bernhard Sixt will provide testimony at ... D.C. on the federal regulation of laboratory developed tests,(LDTs). ... for Devices and Radiological Health (CDRH), the Public Meeting on,Oversight ...
... BROOK, N.J. and BASEL, Switzerland , July ... agreement for the scale-up and commercial production of Anthim, a ... inhaled anthrax. Under the new contract, Lonza will provide process ... its facilities in the USA . The manufacturing process ...
Cached Medicine Technology:Agendia to Provide Testimony at Public Meeting on FDA Oversight of Laboratory-Developed Tests 2Elusys Therapeutics and Lonza Extend Manufacturing Agreement for Anthim, a New Anthrax Treatment in Late-Stage Development 2Elusys Therapeutics and Lonza Extend Manufacturing Agreement for Anthim, a New Anthrax Treatment in Late-Stage Development 3Elusys Therapeutics and Lonza Extend Manufacturing Agreement for Anthim, a New Anthrax Treatment in Late-Stage Development 4
(Date:7/2/2015)... ... July 02, 2015 , ... Global leader and compression ... compression socks designed for men. , For style that’s quick on its feet, ... routine. This is great news for men everywhere because a simple change in socks ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... provides comprehensive information on the pipeline products with comparative analysis of the ... therapy (NPWT) with 22 market data tables and 4 figures, spread across ...
(Date:7/2/2015)... ... July 02, 2015 , ... Breakthrough ... wrist pain treatment. Dr. Lev Kalika, founder of New York Dynamic Neuromuscular ... authority on the conservative treatment of back, hip, knee and shoulder pain as ...
(Date:7/2/2015)... , ... July 02, 2015 , ... Hand sanitizers have ... current summer flu season, according to fresh water advocate and radio host Sharon Kleyne, ... hands. Kleyne cautions that for maximum effectiveness, hand sanitizers must be applied correctly and ...
(Date:7/2/2015)... ... July 02, 2015 , ... The report summarizes key statistics ... report is a valuable source of guidance and direction for companies and individuals ... for the Gelatin Capsule industry including capacity, production, production value, cost and profit, ...
Breaking Medicine News(10 mins):Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 4Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 2Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 2Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 4
... Farms, a national,ground beef producer, is issuing a voluntary ... N.Y., facility and sold through Price,Chopper, Shaw,s, BJ,s, and ... affected product may contain small pieces of hard plastic. ... 05/15/08, or a,"Julian date 124" on the package,s label. ...
... 12 MAP,Pharmaceuticals, Inc. (Nasdaq: MAPP ) today ... 2008., The net loss for the first quarter ... million during the same period in 2007. As of,March ... investments of $81.1 million., First Quarter Financial Results, ...
... prevented heart failure in those with Duchenne muscular dystrophy ... Duchenne muscular dystrophy often suffer from heart failure, but ... condition, a new Canadian study finds. , In experiments ... performance by preventing the breakdown of a compound called ...
... WASHINGTON, May 12 Most baby boomers say,they ... to a,new survey conducted by Harris Interactive on ... would have difficulty paying bills and,many would have ... disability,occurred., (Logo: http://www.newscom.com/cgi-bin/prnh/20040830/AHIPLOGO ), ...
... Effective May 19, the Texas,Hospital Association will have a ... 1108 Lavaca, located within steps of the Texas Capitol., ... Association,and a group of investors, THA was able to ... our members," said Dan Stultz, M.D., FACP, FACHE,president/CEO of ...
... MONTREAL, May 12 /PRNewswire-FirstCall/ - CryoCath(R) Technologies,Inc., the ... announced financial results for the second quarter,ended March 31, ... Highlights:, - Accelerated revenue growth in ... increase over comparable electrophysiology (EP) ...
Cached Medicine News:Health News:Fairbank Farms Issues Voluntary Recall for Selected Ground Beef Products 2Health News:MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results 2Health News:MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results 3Health News:MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results 4Health News:MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results 5Health News:Viagra May Protect Hearts of Some Muscular Dystrophy Patients 2Health News:Most Baby Boomers are Financially Unprepared for a Potential Disability 2Health News:Hospital Association Moves Headquarters to Downtown Austin 2Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 2Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 3Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 4Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 5Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 6Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 7Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 8Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 9Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 10Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 11Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 12
... Airial Handheld Ultrasonic Nebulizer has ... This compact, portable, and lightweight ... fast & quite treatments operating ... or DC auto adapter. , ...
With ten colors available, Spectrums line of Color-Coded Fiberoptic Light Cables makes it easy to track by department....
Lumitex® LightMat® Surgical Illuminator improves visualization in deep cavity surgery. Flexible and malleable, it attaches easily to most retractors, bringing bright, cool area lighting where...
... the exceptional performance you need at a price ... and durability youd expect from headlights priced much ... features our thinnest cable and adjusts from 90 ... when you reach for a headlight you can ...
Medicine Products: